Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare Biotechnology

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

Bullboard Posts

Comment by Stylesson Nov 12, 2013 11:58am

179 Views

Post# 21897701

RE:RE:RE:RE:RE:RE:RE:investors may take a closer look

you might be clinically insane truthseeker.lol

Cipher might need make you a special batch of drugs to treat your illness.

I never lied about anything. I called every move i made ahead of moves for DND shareholders on the board and made countless great calls that i hope people profited on like i did.

Sounds like you're the loser :)

Bullboard Posts

Does Canada have any companies in the computer chip industry?